Does RANIBIZUMAB Cause Intentional product use issue? 223 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 223 reports of Intentional product use issue have been filed in association with RANIBIZUMAB (CIMERLI). This represents 1.5% of all adverse event reports for RANIBIZUMAB.
223
Reports of Intentional product use issue with RANIBIZUMAB
1.5%
of all RANIBIZUMAB reports
18
Deaths
18
Hospitalizations
How Dangerous Is Intentional product use issue From RANIBIZUMAB?
Of the 223 reports, 18 (8.1%) resulted in death, 18 (8.1%) required hospitalization, and 1 (0.4%) were considered life-threatening.
Is Intentional product use issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RANIBIZUMAB. However, 223 reports have been filed with the FAERS database.
What Other Side Effects Does RANIBIZUMAB Cause?
Death (2,250)
Off label use (1,467)
Visual acuity reduced (1,342)
Visual impairment (1,185)
No adverse event (1,012)
Drug ineffective (831)
Blindness (760)
Vision blurred (711)
Eye pain (632)
Cerebrovascular accident (543)
What Other Drugs Cause Intentional product use issue?
INFLIXIMAB (11,028)
RITUXIMAB (9,602)
INFLIXIMAB-DYYB (7,549)
TOCILIZUMAB (5,078)
METHOTREXATE (4,087)
PREDNISONE (3,961)
ABATACEPT (3,693)
ADALIMUMAB (3,557)
NIVOLUMAB (3,297)
LEFLUNOMIDE (3,280)
Which RANIBIZUMAB Alternatives Have Lower Intentional product use issue Risk?
RANIBIZUMAB vs RANIMUSTINE
RANIBIZUMAB vs RANITIDINE
RANIBIZUMAB vs RANITIDINE\RANITIDINE
RANIBIZUMAB vs RANOLAZINE
RANIBIZUMAB vs RAPAMUNE